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ABSTRACT We report investigations of the molecular structure of amyloid ﬁbrils formed by residues 14–23 of the b-amyloid
peptide associated with Alzheimer’s disease (Ab14-23), using solid-state nuclear magnetic resonance (NMR) techniques in
conjunction with electron microscopy and atomic force microscopy. The NMR measurements, which include two-dimensional
proton-mediated 13C-13C exchange and two-dimensional relayed proton-mediated 13C-13C exchange spectra, show that Ab14-23
ﬁbrils contain antiparallel b-sheets with a registry of backbone hydrogen bonds that aligns residue 171k of each peptide
molecule with residue 22k of neighboring molecules in the same b-sheet. We compare these results, as well as previously
reported experimental results for ﬁbrils formed by other b-amyloid fragments, with theoretical predictions of molecular alignment
based on databases of residue-speciﬁc alignments in antiparallel b-sheets in known protein structures. While the theoretical
predictions are not in exact agreement with the experimental results, they facilitate the design of experiments by suggesting a
small number of plausible alignments that are readily distinguished by solid-state NMR.
INTRODUCTION
Amyloid ﬁbrils are ﬁlamentous aggregates formed by a large
class of peptides and proteins with diverse amino-acid se-
quences. Current interest in amyloid ﬁbrils arises from their
involvement in amyloid diseases (including Alzheimer’s dis-
ease, type 2 diabetes, dialysis-related amyloidosis, Parkinson’s
disease, transthyretin amyloidoses, transmissible spongiform
encephalopathy, and others (1)), from the fairly recent real-
ization that the propensity to form amyloid ﬁbrils is not
restricted to disease-associated peptides and proteins (but is
instead a nearly generic property of polypeptides (2)), and
from the possibility that amyloid ﬁbrils may be a useful basis
for development of self-assembled nanomaterials (3,4).
Knowledge of the molecular-level details of amyloid ﬁbril
structures would contribute to our understanding of potential
mechanisms by which amyloid ﬁbrils contribute to or cause
amyloid diseases, to the development of therapeutic agents
(5–7), to our understanding of the intermolecular and intra-
molecular interactions that stabilize amyloid ﬁbrils, and pos-
sibly to the development of amyloid-based nanomaterials.
These molecular-level structural details are only recently
becoming accessible, largely through the application of mod-
ern solid-state nuclearmagnetic resonance (NMR) techniques
such as multiple quantum NMR (8–10), dipolar recoupling
(11–21), and various forms ofmultidimensional spectroscopy
(10,18,19,22–26) in conjunction with magic-angle spinning
(MAS). Solid-state NMR measurements have revealed that
amyloid ﬁbrils, which are known to be primarily b-sheet
structures from x-ray ﬁber diffraction patterns (27–29), can
contain either parallel or antiparallel b-sheets, depending on
the amino-acid sequence. To date, antiparallel b-sheets have
only been observed in ﬁbrils formed by relatively short
peptides that contain one b-strand segment (10,12,19). The
precise registry of backbone hydrogen bonds (i.e., the
alignment of neighboring b-strands within a single b-sheet)
can be pH-dependent (19) and is not fully determined by the
local amino acid sequence (e.g., by seven-residue segments).
Not all short peptides form antiparallel b-sheets in amyloid
ﬁbrils (20,30), and the b-sheets in ﬁbrils formed by short
peptides can be switched from antiparallel to parallel by
attachment of N-terminal alkyl chains (31).
Techniques other than solid-state NMR have also contrib-
uted greatly to our developing understanding of amyloid
structures. These techniques include electron microscopy
(32–36), x-ray crystallography (30,37), electron paramag-
netic resonance (38–42), hydrogen/deuterium exchange
(25,43–47), chemical cross-linking (13,48), limited proteol-
ysis (49,50), and scanningmutagenesis (51–53). Results from
these techniquesaregenerallyconsistentwith those fromsolid-
state NMR, especially with regard to the types of b-sheets
contained in amyloid ﬁbrils.
In this article, we report the results of solid-state NMR
measurements on ﬁbrils formed by residues 14–23 of the
full-length b-amyloid peptide associated with Alzheimer’s
disease (Ab14-23, sequence Ac-HQKLVFFAED-NH2, with
acetyl and amide capping groups at the N- and C-termini).
We have chosen to study Ab14-23 for the following reasons:
1. In earlier work, Tjernberg et al. (54) examined amyloid
ﬁbril formationbyb-hairpinpeptides containing theAb14-23
sequence on both sides of a type 19 b-turn, constrained to
align either residue 171k with residue 20k or residue
171k with residue 21k (54). Both b-hairpin peptides
were found to form ﬁbrils, raising the question of what
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alignment is preferred by the unconstrained Ab14-23
peptide in amyloid ﬁbrils (including the possibility of
either antiparallel or parallel b-sheet structure).
2. Although the hexapeptide Ac-KLVFFAE-NH2 has been
shown to form amyloid ﬁbrils (10), other b-amyloid-
derived peptides containing the LVFFA hydrophobic
segment and a total of nine or fewer residues were found
by Tjernberg et al. not to form ﬁbrils (55), while all
peptides examined that contained 11 or more residues
did form ﬁbrils (19,55). Residues 14–23 may therefore
be considered the minimal segment of the b-amyloid
sequence that is sufﬁcient for ﬁbril formation.
3. Given that our current understanding of amyloid structures
and the interactions that stabilize these structures is re-
latively primitive (e.g., compared with our understanding
of soluble, monomeric, globular protein structures), struc-
tural studies of model systems such as Ab14-23 ﬁbrils are
expected to contribute important information about the
variety and sequence dependence of amyloid structures
and stabilizing interactions.
4. Model systems such asAb14-23 ﬁbrils serve as test-beds for
thedevelopment anddemonstrationof experimentalmethods
for determining speciﬁc features of amyloid structures and
theoretical methods for predicting these structural features.
The solid-state NMRmeasurements described below show
that Ab14-23 ﬁbrils contain antiparallel b-sheets with hydro-
gen-bond registry that aligns residue 171k with residue
22k, for integral k (e.g., V18 of eachAb14-23molecule forms
hydrogen bonds with A21 of a neighboring molecule in the
same b-sheet). Moreover, the solid-state NMR data indicate a
high level of order in the b-sheets, with no detectable defects
in the 171k4 22k hydrogen-bond registry. We compare
these experimental results with theoretical predictions of
b-strand alignment. In particular, we show that simple pre-
dictive tools based upon comparisons with known protein
structures may be useful in guiding experimental design, alt-
hough precise prediction of registry may not be possible.
METHODS
Peptide synthesis and ﬁbril formation
Isotopically labeled amino acids were obtained from Cambridge Isotope
Laboratories (Andover, MA). Ab14-23 peptides containing labeled amino
acids were synthesized on a Symphony/Multiplex solid-phase synthesizer
(Protein Technologies, Tucson, AZ), using standard FMOC synthesis and
cleavage protocols. Peptides were puriﬁed by high performance liquid
chromatography using two mobile phases, water with 0.1% triﬂuoroacetic
acid and acetonitrile with 0.1% triﬂuoroacetic acid, on a C18 reverse phase
column (Grace Vydac, Hesperia, CA). Final purity was.95%, as conﬁrmed
by aKompactMALDITOFmass spectrometer (Kratos,ChestnutRidge,NY).
After lyophilization of the high performance liquid chromatography fraction
containing these peptides, Ab14-23 was dissolved at 5.3 mg/ml in 10 mM
phosphate buffer, 0.01%NaN3, at pH4.7. Fibrils formedwithin threeweeks at
room temperature. Ab14-23 ﬁbril sampleswere preparedwith uniform
13C and
15N labeling of L17 and F20 (17,20-Ab14-23), V18 and F20 (18,20-Ab14-23),
V18 and A21 (18,21-Ab14-23), and L17 and A21 (17,21-Ab14-23).
Electron microscopy and atomic
force microscopy
Fibril formation was conﬁrmed and ﬁbril dimensions were determined using
electron microscopy (EM) and atomic force microscopy (AFM). For EM
measurements, 10 ml aliquots of incubated Ab14-23 solutions were placed on
specimen grids covered by a formvar/carbon support ﬁlm. Excess ﬂuid was
wicked off after 2 min and the grids were negatively stained with 4 mg/ml
uranyl acetate in water. The stained grids were then examined and
photographed with a JEOL (Tokyo, Japan) JEM-100CXII transmission
electron microscope.
For AFM, ﬁbrils were diluted in 0.5% acetic acid (pH 3) to a peptide
concentration of ;0.5 mM. Both lyophilized and fully hydrated (i.e., never
lyophilized or dried after incubation) ﬁbrils were examined. A 50 ml aliquot
was placed on freshly cleavedmica (1 cm2 area), allowed to adsorb for several
minutes, and drained from the mica surface. The surface was washed twice
with 100 ml of 0.5% acetic acid, then dried under a stream of nitrogen gas.
AFM images were obtained in air with a MultiMode AFM system (Veeco
Instruments, Santa Barbara, CA) in tapping mode, using microactuated
probes with a nominal force constant of 3 N/m and a nominal tip radius of
curvature of 10 nm. Approximately 100 images of 5 mm3 5 mm areas were
recorded for both lyophilized and hydrated samples, with 1024 pixel
resolution in each lateral dimension. AFM images in Fig. 1 b are portions of
typical 5 mm 3 5 mm areas.
Solid-state NMR
NMR measurements were carried out at a magnetic ﬁeld of 14.1 T (150.7
MHz 13C NMR frequency) using Varian (Palo Alto, CA) Inﬁnity and
InﬁnityPlus spectrometer consoles and a Varian MAS probe with 3.2 mm
MAS rotor diameters and 11 ml maximum sample volumes. Additional
Teﬂon plugs were inserted in the rotors to restrict smaller samples to the
center of the radio-frequency (rf) coil in the NMR probe. Ab14-23 ﬁbril
samples were pelleted in a microfuge (18,0003 g for 15 min), resuspended
FIGURE 1 (a) Transmission electron microscope image of Ab14-23 ﬁbrils,
with negative staining. (b) Atomic force microscope images of Ab14-23
ﬁbrils with (left) and without (right) lyophilization before dilution in 0.5%
acetic acid and deposition on mica. Grayscales indicate height.
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in deionized H2O, and lyophilized before packing into MAS rotors. Sample
quantities were in the 2–6mg range. Lyophilization permitted the use of small
sample volumes with concomitantly high MAS speeds, rf ﬁeld amplitudes,
and NMR sensitivity. As shown by AFM images (Fig. 1 b), lyophilization
breaksAb14-23 ﬁbrils into 100-500 nm segments but does not otherwise affect
ﬁbril morphology. For certain measurements (speciﬁed below), lyophilized
samples were rehydrated by addition of 2–3 ml of deionized H2O.
Rf pulse sequences used in solid-stateNMRmeasurements are shown inFig.
2. One-dimensional 13C NMR spectra (Fig. 2 a) were recorded with cross-
polarization (CP) from protons (56) and with two-pulse phase-modulated
protondecoupling (57).Decouplingﬁeldswere 110kHz. 13C rfﬁeldswere;50
kHz during CP, with tangent-shaped amplitude modulation. Two-dimensional
proton-mediated 13C-13C NMR exchange (2D-PME) spectra were recorded as
described previously (19,58), using 150 ms CP periods, 200 ms proton spin
diffusion (SD) periods in the exchange period, and MAS frequencies of 20.0–
21.4 kHz (Fig. 2 b). Under these conditions, strong crosspeaks are observed
between the NMR lines of 13C pairswith directly-bonded protons for which the
proton-proton distances are ,3 A˚. In particular, strong intermolecular cross-
peaks betweenNMR lines of 13C-labeleda-carbons (Ca) are detectedwhen the
corresponding residues are aligned in antiparallel b-sheets, leading to inter-
molecular distances of;2.2 A˚ between a-protons (Ha). Thus, the presence or
absence of particular Ca/Ca crosspeaks in 2D-PME spectra can be used to
determine hydrogen-bond registry in antiparallel b-sheets (19,58).
Ca chemical shifts for L17 and F20 were found to be similar (0.7 ppm
difference), preventing the observation of Ca/Ca crosspeaks in 2D-PME
spectra of 17,20-Ab14-23 ﬁbrils even if L17 and F20 were aligned in
antiparallel b-sheets. Therefore, a new solid-state NMR technique was
designed in which alignment of uniformly 13C-labeled residues could be
detected as an intermolecular crosspeak between carbonyl (CO) NMR lines.
In this technique, called two-dimensional relayed proton-mediated 13C-13C
NMR exchange (2D-RPME) spectroscopy (Fig. 2 c), 13C spin polarization
is transferred between CO sites during the exchange period in ﬁve steps:
1. A short 13C-13C dipolar recoupling period for intraresidue CO/Ca
transfer.
2. A short CP period for one-bond Ca/Ha transfer.
3. A short proton SD period for intermolecular Ha/Ha transfer.
4. A second short CP period for one-bond Ha/Ca transfer.
5. A second short 13C-13C dipolar recoupling period for intraresidue
Ca/CO transfer. CP and SD conditions are the same as in 2D-PME
measurements.
13C-13C dipolar recoupling periods employed the radio-frequency-driven
recoupling pulse sequence (59,60), with one 8.0 ms 13C p-pulse per MAS
rotation period for a total of 16 rotation periods (1.067 ms at a 15.0 kHz
MAS frequency). 13C p-pulse phases followed the XY-16 pattern (61).
RESULTS
Electron microscopy and atomic
force microscopy
The EM image in Fig. 1 a shows that Ab14-23 forms ﬁbrils
with an apparently ﬂat, ribbonlike morphology, with ﬁbril
widths of;30 nm. Fibril widths exceed the 3.5 nm length of
a single Ab14-23 molecule in a fully extended b-strand
conformation, suggesting that each ﬁbril contains many ﬁner
ﬁlaments with cross-b structures.
The AFM images in Fig. 1 b show that lyophilization
breaks long Ab14-23 ﬁbrils into shorter fragments, which
tend to coalesce into clumps under the conditions of AFM
measurements, but otherwise has no detectable effect on
ﬁbril morphology. Apparent ﬁbril heights in AFM images of
both lyophilized and hydrated ﬁbrils are 2.5 6 0.5 nm. The
ﬁbril heights may correspond to the thickness of between
two and four b-sheets in a laminated cross-b structure.
Solid-state NMR
Fig. 3 shows one-dimensional 13C MAS NMR spectra of
the four Ab14-23 ﬁbril samples examined in this work.
13C
chemical shift assignments, summarized in Table 1, are based
on the known chemical shift ranges for individual carbon sites
in amino acids, and are conﬁrmed by the 2D-NMR spectra
described below. Chemical shifts for CO, Ca, and b-carbon
(Cb) sites are consistent with a b-strand conformation for
residues 17–21 in Ab14-23 ﬁbrils (i.e., upﬁeld secondary shifts
relative to random coil values (62) for CO and Ca, downﬁeld
secondary shifts for Cb). Only the Ca line for L17 does not
show a strong secondary shift. In the dry, lyophilized state,
13CMASNMR line-widths for resolved single sites are 1.5 to
2.1 ppm (full width at half-maximum). In the rehydrated state
(Fig. 3, a and b, bottom spectra), line-widths are 1.0 ppm. The
reduction of 13C MAS NMR line-widths upon rehydration is
attributable to increased molecular motion, which partially
averages out the inhomogenous broadening that arises from
structural variations within these noncrystalline ﬁbril sam-
ples. Structural variations that may contribute to the observed
FIGURE 2 Radio-frequency pulse sequences for one-dimensional 13C
MAS NMR measurements (a), 2D-PME measurements (b), and 2D-RPME
measurements (c). Radio-frequency-driven recoupling periods consist of one
13C p pulse per MAS rotor period. Dephasing delays t are 1 ms. Phase
cycles are: f1 ¼ x, x; f2 ¼ x, x, x, x; f3 ¼ x or y for real or imaginary
signals in t1; f4 ¼ x, x, y, y, x, x, y, y; f5 ¼ x, x, x, x, y, y, y, y, x,
x, x, x, y, y, y, y. Receiver phase cycles are x, x, y, y, x, x,
y, y in panel a and x, x, x, x, y, y, y, y, x, x, x, x, y, y, y, y in
panels b and c.
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line-widths include variations in backbone torsion angles
within the b-strand segments by ;610, variations in side-
chain conformations, disorder at the extremeN- andC termini
of Ab14-23, variations in contacts between the ﬁne ﬁlaments
that presumably comprise the ﬁbrils shown in Fig. 1, and
variations in the number of or contacts betweenb-sheet layers
within these ﬁlaments. When compared with the 2–3 ppm
line-widths observed in 13C MAS NMR spectra of other
noncrystalline systems, including peptide/antibody com-
plexes (63,64) and helical proteins (65–67) in frozen solutions
as well as other amyloid ﬁbrils (17,21,22), the line-widths in
Fig. 3 indicate a high degree of structural order, but without
true crystallinity.
In solid-state MAS NMR studies of microcrystalline
proteins, 13C NMR line-widths ,1 ppm are commonly
observed at moderate temperatures (68–70). The line-widths
increase substantially at low temperatures, where solvent
within the crystal is immobilized and protein motions are
quenched (71), although crystalline order is not lost. We infer
from the 13C NMR line-widths that the level of molecular
conformational order in Ab14-23 ﬁbrils is similar to, but not as
high, as in microcrystalline proteins because 13C NMR lines
for hydrated Ab14-23 ﬁbrils are not as narrow as
13C NMR
lines for microcrystalline proteins. Hydrated amyloid ﬁbrils
formed by the HET-s protein of Podospora anserina have
been shown by Siemer et al. to exhibit NMR line-widths on
the order of 0.1 ppm (26), possibly because HET-s ﬁbrils
are responsible for an evolved biological function (namely,
heterokaryon incompatibility (72)) and therefore have a
highly homogeneous molecular structure.
Fig. 4 shows 2D-PME spectra of the four Ab14-23 ﬁbril
samples. In the 2D-PME spectrum of 18,21-Ab14-23 ﬁbrils,
strong crosspeaks (25% of diagonal peaks) are observed
between Ca NMR lines of V18 and A21. Ca/Ca crosspeaks
are not observed above the noise level in any of the other 2D-
PME spectra. This result implies that Ab14-23 ﬁbrils con-
tain antiparallel b-sheets in which V18 aligns with A21, i.e.,
antiparallel b-sheets with 171k 4 22–k hydrogen-bond
registry. Ca/Ca crosspeak intensities for 18,21-Ab14-23 ﬁbrils,
relative to diagonal peak intensities, are approximately the
same as in previously reported 2D-PME spectra of Ab16-22
and Ab11-25 ﬁbrils for the Ca pairs that are aligned in anti-
parallel b-sheets in these ﬁbrils (19,58). For example, under
quite similar experimental conditions, Ca/Ca crosspeaks for
V18/F20 and L17/A21 pairs in 2D-PME spectra of Ab16-22
ﬁbrils (which have 171k4 21–k registry (10)) were found to
have 28% of the volume of V18 and A21 Ca diagonal peaks
(58). The observed crosspeak intensities for 18,21-Ab14-23
ﬁbrils indicate that all V18 and A21 residues in Ab14-23 ﬁbrils
participate in the 171k422k registry. Any putative alter-
nations in registry (e.g., as previously suggested for Ab34-42
ﬁbrils (12)) or alternations between antiparallel and parallel
b-sheet alignments would reduce the V18/A21 crosspeak in-
tensities by at least a factor of two. Structures with alternating
registry or alignment would also necessarily contain two or
more inequivalent environments for Ab14-23 molecules (i.e.,
more than one molecule in the asymmetric unit), potentially
splitting each 13CNMR line into two ormore components. No
splittings are observed in the one- or two-dimensional spectra
of Ab14-23 ﬁbrils.
The absence of detectable Ca/Ca crosspeaks in the 2D-
PME spectra of 18,20-Ab14-23 and 17,21-Ab14-23 ﬁbrils
FIGURE 3 One-dimensional 13C MAS NMR spectra of Ab14-23 ﬁbrils
with uniform 13C and 15N labeling of L17 and F20 (a), V18 and A21 (b),
V18 and F20 (c), and L17 and A21 (d). Spectra were recorded at a 13C NMR
frequency of 150.7 MHz, with MAS frequencies of ;20 kHz and between
64 and 256 scans.
TABLE 1 13C NMR chemical shifts in Ab14-23 ﬁbrils
Residue CO Ca Cb Cg Cd
L17 172.8 (175.9) 53.3 (53.4) 44.5 (40.7) 24.7 (25.2) 23.8 (23.2, 21.6)
V18 169.8 (174.6) 59.2 (60.5) 34.1 (31.2) 19.6 (19.4, 18.6)
F20 169.5 (174.1) 54.0 (56.0) 43.0 (37.9) 136.5 (137.2)
A21 172.5 (176.1) 48.6 (50.8) 21.4 (17.4)
Values are in ppm relative to tetramethylsilane, based on an external reference of 177.95 ppm for the carboxylate line of polycrystalline L-alanine. Values in
parentheses are random coil chemical shifts, taken from Wishart et al. (62) and adjusted to the tetramethylsilane reference by subtraction of 1.7 ppm.
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places a constraint on the levels of certain defects in the
antiparallel b-sheets. In particular, defects that produce
171k4 21k alignments cannot be present at levels above
10%. This upper limit on defect concentration is dictated by
the signal/noise ratio in the 2D-PME spectra.
Fig. 5 shows 2D-RPME spectra of 17,20-Ab14-23 and
18,21-Ab14-23 ﬁbrils. As explained above, the 2D-RPME
technique allows hydrogen-bond registry to be investigated
in cases where the Ca NMR lines are not resolved. The 2D-
RPME spectrum of 17,20-Ab14-23 shows only intraresidue
crosspeaks, including crosspeaks between the CO line of
L17 (172.8 ppm) and aliphatic carbon lines of L17 (53.3,
44.5, and 24.7 ppm) and crosspeaks between the CO line of
F20 (169.5 ppm) and aliphatic lines of F20 (54.0 and 43.0
ppm). In contrast, the 2D-RPME spectrum of 18,21-Ab14-23
ﬁbrils shows both intraresidue and interresidue crosspeaks,
including crosspeaks between the CO line of V18 and the
CO line of A21, crosspeaks between the CO line of V18 and
aliphatic lines of A21, and crosspeaks between the CO line
of A21 and aliphatic lines of V18. Although the signal/noise
ratio is higher in the 2D-RPME spectrum of 18,21-Ab14-23
ﬁbrils (due to a larger sample quantity), the signal/noise ratio
in the 2D-RPME spectrum of 17,20-Ab14-23 ﬁbrils is high
enough to permit the observation of interresidue crosspeaks
if they were present. The data in Fig. 5 conﬁrm the 171k4
22k hydrogen-bond registry in Ab14-23 ﬁbrils. In addition,
these data demonstrate the utility of the 2D-RPME technique
in structural investigations of amyloid ﬁbrils.
Comparison of the 2D-PME and 2D-RPME data for 18,21-
Ab14-23 (Figs. 4 and 5) indicates that the total
13CNMR signal
amplitude in the 2D-RPME spectrum (i.e., the integrated
signal in the ﬁrst one-dimensional spectrum, at t1 ¼ 0) is
;25% greater in the 2D-RPME measurement for the same
number of scans. Each interresidue crosspeak in the 2D-
RPME spectrum has ;15–30% of the volume of the inter-
residue Ca/Ca crosspeaks in the 2D-PME spectrum.
DISCUSSION
Summary of experimental ﬁndings
EMandAFM images in Fig. 1 demonstrate thatAb14-23 forms
amyloidﬁbrils, as observedpreviously formanyother fragments
FIGURE 4 (a) Aliphatic regions of 2D-PME spectra of lyophilized Ab14-23
ﬁbrils with the indicated labeled residues. Single-headed arrows indicate
assignments of certain intraresidue crosspeaks. Double-headed arrow
indicates an interresidue crosspeak. (b) One-dimensional slices at the
indicated Ca chemical shifts. Double-headed arrows indicate the only
interresidue crosspeaks observed in these measurements. Spectra were
recorded in 24–72 h, using recycle delays of 2 s and maximum t1 periods of
3.8 ms.
FIGURE 5 (a) 2D-RPME spectra of rehydrated Ab14-23 ﬁbrils with the
indicated labeled residues. (b) One-dimensional slices at the indicated CO
chemical shifts. Spectra were recorded in 48–72 h, using recycle delays of
1.6 s and maximum t1 periods of 2.3 ms.
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of theAlzheimer’sb-amyloid peptide (10,12,13,19).As in the
case of ﬁbrils formed by other short fragments (10,19), the
ﬁbril widths exceed the maximum length of a single peptide
chain, suggesting that the observed ﬁbrils are comprised of
multiple ﬁner ﬁlaments that cannot be resolved in the images.
One-dimensional 13C NMR spectra of isotopically labeled
Ab14-23 ﬁbrils in Fig. 3 indicate a high degree of structural
order at the molecular level. 13C NMR chemical shifts
indicate that residues 17–21 form a continuous b-strand. The
2D-PME and 2D-RPME spectra in Figs. 4 and 5 show that the
b-sheets are of the antiparallel type, with a registry that
produces a distance,3 A˚ between Ha sites of V18 and A21.
Given theb-strand conformation of residues 17–21, this must
be an intermolecular distance. Only 171k4 22k registry is
consistent with the data. Any alternation in registry or
alignment within the b-sheets would be inconsistent with the
intensity of Ca-Ca crosspeaks in the 2D-PME spectrum of
18,21-Ab14-23 ﬁbrils and the absence of splittings of any
13C
NMR lines. Amolecular model for the antiparallelb-sheets in
Ab14-23 ﬁbrils is shown in Fig. 6.
Antiparallel b-sheets have been established by previous
solid-state NMRmeasurements on Ab11-25 (19), Ab16-22 (10)
and Ab34-42 (12) ﬁbrils. The registry in Ab16-22 ﬁbrils pre-
pared at pH 7.4 is 171k421k, while the registry in Ab11-25
ﬁbrils is 171k420k at pH 7.4 and 171k422k at pH 2.4.
Thus, the b-sheet structure in Ab14-23 ﬁbrils prepared at pH
4.35 is the same as in Ab11-25 ﬁbrils prepared at low pH.
As observed in solid-state NMR studies of amyloid ﬁbrils
formed by other peptides (19,20,73), 13C NMR chemical
shifts in lyophilized and hydrated Ab14-23 ﬁbrils are indistin-
guishable, indicating that the molecular structure is not
affected signiﬁcantly by hydration. Hydration produces a re-
duction in 13CNMR line-widths, also as previously observed.
From a practical standpoint, lyophilized samples have the
advantages of permitting the use of highMAS frequencies, as
required for certain solid-state NMR measurements (74–76),
and small sample volumes, which in turn permit high rf ﬁelds
and high sensitivity. Lyophilized samples are not prone to rf-
induced heating and toNMRprobe tuning instabilities. On the
other hand, hydrated samplesmay be preferred in experiments
where the highest possible spectral resolution is required.
Similar line-widths have been observed in spectra of samples
that are fully hydrated without prior lyophilization (19) and in
spectra of samples that were lyophilized and subsequently
rehydrated (20,73).
Theoretical predictions
We now compare the experimental results with theoretical
predictions of hydrogen-bond registry in antiparallelb-sheets.
These predictions were made in advance of the experiments
andwere used to select the isotopic labeling patterns and solid-
state NMR strategies described above.
The relative probability of a given registry can be estimated
from the probability that such an alignment occurs in known
protein structures (54). This probability is calculated from the
relative probability that individual pairs of residues align in an
antiparallel b-sheet in known protein structures, which we
take from the database of Wouters and Curmi (77,78). Spe-
ciﬁcally, Wouters and Curmi report pair-correlation values
CijHB andC
ij
NHB for all pairs of amino acids i and j, representing
the ratio of the observed occurrence of i and j in positions of
interstrand alignment (in a set of 253 nonredundant protein
structures) to the predicted occurrence of i and j in positions
of interstrand alignment if all amino acids in the antiparallel
b-sheets were randomly distributed (77). Wouters and Curmi
distinguish between hydrogen-bonded (HB) and non-hydro-
gen-bonded (NHB) alignments, which they ﬁnd to have sig-
niﬁcantly different pair correlation values. We calculate the
relative probability for a given registry of a given peptide
sequence in antiparallel b-sheets in an amyloid ﬁbril by
multiplying the relevant CijHB and C
ij
NHB values for all aligned
residue pairs in that registry. Residues that are unpaired in a
given registry (i.e., dangling residues) are assigned a pair cor-
relation value of 1. If the calculated probability is denoted by
P, the relative free energy of binding for a given peptide
registry is then given by DG ¼ RT ln(P), where T is the
temperature and R is the gas constant.
Note that each aligned residue pair occurswith bothHBand
NHB alignments in the antiparallel b-sheets under consider-
ation here, because all b-strands have the same amino-acid
sequence and because we consider only b-sheet structures
with maximal symmetry. Therefore, we must evaluate two
alignment probabilities (for the two combinations of HB and
FIGURE 6 (a) Molecular model for an antiparallel b-sheet in Ab14-23
ﬁbrils, with the registry of backbone hydrogen bonds indicated by the solid-
state NMR data in Figs. 4 and 5. (b) One-letter-code representation, showing
hydrogen-bonded (red lines) and non-hydrogen-bonded (yellow lines)
interstrand alignments of amino-acid pairs. Two different sets of alignments
(i.e., patterns of red and yellow lines) alternate along the hydrogen-bonding
direction of the antiparallel b-sheet, making two distinct contributions to the
calculated free energy.
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NHB alignments that alternate along the hydrogen-bonding
direction of the b-sheet; see Fig. 6 b and accompanying
caption for clariﬁcation) and two free energies. The ﬁnal free
energy is taken to be the average of the two.
Fig. 7 shows this free energy as a function of the offset N,
deﬁned by requiring that residue 171k be aligned with res-
idue Nk of neighboring peptide chains in the b-sheet. For
Ab14-23, the solid-state NMR results indicate that N ¼ 22, so
that V18 aligns with A21. Solid-state NMR data indicate that
N¼ 21 for Ab16-22 ﬁbrils grown at pH 7.4, while for Ab11-25
ﬁbrils,N¼ 20 at pH 7.4 andN¼ 22 at pH 2.4. Calculated free
energies predict N ¼ 21 for all three peptides. In all three
cases, the experimental offset is within a deepminimumof the
predicted relative free energy. Thus, this simple predictive
scheme may be useful to guide experimental design (for in-
stance, by suggesting which residues should be isotopically
labeled for solid-state NMR investigations), but does not
capture all factors that determine the precise hydrogen-bond
registries.
It is interesting to note that the offset required for all
residues to participate in an antiparallel b-sheet (i.e., to have
no dangling residues) is 21 for Ab16-22, but 20 for Ab14-23
and 19 for Ab11-25. Thus, if one were to attempt to improve
the calculation by adding a free energy contribution biased
against the number of dangling residues, one could improve
the prediction in the case of Ab11-25 ﬁbrils at pH 7.4 but
would worsen it in the other two cases.
We have also used the pair-information values Pi,j1m
introduced by Steward and Thornton (79) to evaluate the
relative probabilities of various registries, as previously
described by Petkova et al. (19) The pair-information values
take into account interstrand interactions between residues
that are not directly aligned. For a given registry, we evaluate
the sum of Pi,j1m values for m ¼ 1, 0, and 1 (i.e., directly
aligned residue pairs, and pairs that are shifted by one residue
in either direction) and for i being residues 17, 18, 19, 20,
and 21. Pi,j1m values for hydrogen-bonded and non-hydro-
gen-bonded pairs i and j are added together, because both
types of pairing are present for each residue in the b-sheet
structures under consideration. Total information scores are
450, 795, 1042, and 576 for N equal to 19, 20, 21, and 22,
respectively. Replacing Asp by Asn and Glu by Gln to ap-
proximate the effects of low pH, the total scores become 450,
895, 1036, and 653. If we set Pi,j1m¼ 0, so that only directly
aligned residues are considered, the scores are 80, 412, 631,
and 204 at neutral pH, and 80, 412, 631, and 416 at low pH.
Thus, the most likely registry according to the pair-information
value treatment is always 171k4 21k, in agreement with
the free energy calculations in Fig. 7.
More sophisticated and accurate schemes could be formu-
lated by including structural effects or energetics derived from
other experimental techniques (80). The approaches described
above do not take into account interactions between b-sheet
layers, which have been elucidated experimentally in Ab1-40
ﬁbrils (81) and GNNQQNY ﬁbrils (30), but not in the ﬁbrils
discussed above. In Ab14-23 and Ab11-25 ﬁbrils, it is not yet
known whether residues at the N- and C-termini are structur-
ally ordered and participate in the antiparallel b-sheets. The
171k4 22k registry observed inAb14-23 ﬁbrils necessarily
leaves H14 and Q15 unpaired and outside the b-sheets.
Entropy associatedwith these residuesmay favor the observed
registry over the predicted 171k4 21k registry. In addi-
tion, the 171k4 22k registry results in antiparallelb-sheets
with two equivalent faces. Side chains of F19 and F20 create
continuous rows of aromatic rings on each face, as shown in
Fig. 6. These and other features may be advantageous from
the standpoint of interactions between b-sheet layers.
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